VISTAGEN THERAPEUTICS, INC. Finance Lease, Liability, Noncurrent
VISTAGEN THERAPEUTICS, INC. (VTGN) had Finance Lease, Liability, Noncurrent of $6.00 thousand as of 2023-12-31, per its 10-Q filed 2024-02-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2024-02-13
- 2023-12-31: Finance Lease, Liability, Noncurrent $6.00K.
- 2023-09-30: Finance Lease, Liability, Noncurrent $6.50K.
- 2023-06-30: Finance Lease, Liability, Noncurrent $7.00K.
- 2023-03-31: Finance Lease, Liability, Noncurrent $7.40K.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2023-12-31 | $6.00K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $6.50K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $7.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $7.40K 10-Q · filed 2024-02-13 |
| 2022-12-31 | $7.90K 10-Q · filed 2023-02-07 |
| 2022-09-30 | $8.30K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.70K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 |
| 2021-03-31 | $0.00 10-K · filed 2021-06-29 |
| 2020-03-31 | $3.00K 10-K · filed 2021-06-29 |
| 2019-03-31 | $6.30K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |